reboxetine has been researched along with moclobemide in 6 studies
| Studies (reboxetine) | Trials (reboxetine) | Recent Studies (post-2010) (reboxetine) | Studies (moclobemide) | Trials (moclobemide) | Recent Studies (post-2010) (moclobemide) |
|---|---|---|---|---|---|
| 626 | 193 | 184 | 788 | 240 | 113 |
| Protein | Taxonomy | reboxetine (IC50) | moclobemide (IC50) |
|---|---|---|---|
| Amine oxidase [flavin-containing] A | Rattus norvegicus (Norway rat) | 7.7 | |
| Amine oxidase [flavin-containing] A | Homo sapiens (human) | 4.1522 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (33.33) | 29.6817 |
| 2010's | 3 (50.00) | 24.3611 |
| 2020's | 1 (16.67) | 2.80 |
| Authors | Studies |
|---|---|
| Carpentier, C; Costentin, J; Leroux-Nicollet, I; Naudon, L; Vilpoux, C | 1 |
| Cryan, JF; Lucki, I; Page, ME | 1 |
| Fisar, Z; Hroudová, J; Raboch, J | 1 |
| Choong, E; Eap, CB; Guillarme, D; Haldemann, S; Kottelat, A; Rudaz, S; Veuthey, JL | 1 |
| Niedzielska, E; Nowak, G; Pałucha-Poniewiera, A; Pilc, A; Pomierny, B; Pomierny-Chamioło, L; Siwek, A | 1 |
| Keidan, L; Pick, CG; Schreiber, S | 1 |
6 other study(ies) available for reboxetine and moclobemide
| Article | Year |
|---|---|
Differential effects of chronic antidepressant treatments on micro- and delta-opioid receptors in rat brain.
Topics: Animals; Antidepressive Agents; Autoradiography; Binding Sites; Brain; Enkephalin, Ala(2)-MePhe(4)-Gly(5)-; Enkephalin, D-Penicillamine (2,5)-; Injections, Intraperitoneal; Male; Moclobemide; Morpholines; Paroxetine; Rats; Rats, Sprague-Dawley; Reboxetine; Receptors, Opioid, delta; Receptors, Opioid, mu; Time Factors | 2002 |
Differential behavioral effects of the antidepressants reboxetine, fluoxetine, and moclobemide in a modified forced swim test following chronic treatment.
Topics: Animals; Antidepressive Agents; Behavior, Animal; Fluoxetine; Male; Moclobemide; Morpholines; Rats; Rats, Sprague-Dawley; Reboxetine; Swimming | 2005 |
Inhibition of monoamine oxidase activity by antidepressants and mood stabilizers.
Topics: Affect; Amitriptyline; Animals; Antidepressive Agents; Antimanic Agents; Benzodiazepines; Cerebral Cortex; Citalopram; Clorgyline; Cocaine; Cyclohexanols; Desipramine; Fluoxetine; Imipramine; In Vitro Techniques; Iproniazid; Lithium; Mianserin; Mirtazapine; Mitochondria; Moclobemide; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Morpholines; Olanzapine; Pargyline; Reboxetine; Swine; Thiazepines; Valproic Acid; Venlafaxine Hydrochloride | 2010 |
Quantification of 4 antidepressants and a metabolite by LC-MS for therapeutic drug monitoring.
Topics: Antidepressive Agents; Bupropion; Chromatography, High Pressure Liquid; Drug Monitoring; Drug Stability; Humans; Moclobemide; Morpholines; Reboxetine; Reproducibility of Results; Sensitivity and Specificity; Solid Phase Extraction; Spectrometry, Mass, Electrospray Ionization; Trazodone | 2011 |
Prolonged administration of antidepressant drugs leads to increased binding of [(3)H]MPEP to mGlu5 receptors.
Topics: Animals; Antidepressive Agents; Blotting, Western; Brain; Cerebral Cortex; Citalopram; Excitatory Amino Acid Antagonists; Hippocampus; Imipramine; Male; Moclobemide; Morpholines; Pyridines; Radioligand Assay; Rats, Wistar; Reboxetine; Receptor, Metabotropic Glutamate 5; Thiazoles; Tritium | 2014 |
Treatment-Resistant Depression (TRD): Is the Opioid System Involved?
Topics: Analgesics, Opioid; Animals; Antidepressive Agents; Depression; Dose-Response Relationship, Drug; Fluoxetine; Fluvoxamine; Mianserin; Mice; Mirtazapine; Moclobemide; Naloxone; Reboxetine; Trazodone; Venlafaxine Hydrochloride | 2023 |